CDKN2A and neoplasm: This effect is a protective mechanism known as oncogene-induced senescence [26] and is related to the preservation of tumor suppressors, including TP53 and PTEN, which results in melanocyte senescence and cell cycle arrest by activating p15INK4b, p16INK4a, p19, and acidic β-galactosidase [5].